Funded Tech Companies
Syntax Bio
Syntax Bio, based in Chicago, received equity investments from JDRF T1D Fund, Astellas Venture Capital and Illumina Ventures.
Company Overview
Company Name
Syntax Bio
Company Status
Private & Independent
Industry
Life Sciences
Funding Rounds
Total Funding
Contact Information
Mailing Address
400 N Aberdeen, 9th Floor 9
Chicago, IL 60642
USA
Chicago, IL 60642
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Syntax Bio is a preclinical-stage biotech company overcoming the longstanding challenges in stem cell-derived therapies by directly controlling and accelerating cell differentiation. Our Cellgorithm technology provides control over the complex developmental biology needed to manufacture stem cell-derived cell therapies.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
12/10/2025
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Flavin
Chief Technical Officer
Ryan Clarke
Co-Founder
Niko Balanis
Co-Founder
Brad Merrill
VP - Sales
Nick Timmins
Company Investors
- JDRF T1D Fund
- Astellas Venture Capital
- Illumina Ventures
- Civilization Ventures
- EGB Ventures
- DCVC Bio
- Portal Innovations
Browse more funded tech companies:
Share this article
About Our VC Deals Database
Our data comes from VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs